Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease

被引：8

作者：

Salim, Sohail Abdul ^{[1
]}

Nair, Lakshmi Ramachandran ^{[2
]}

Thomas, Litty ^{[1
]}

Garla, Vishnu ^{[2
]}

Palabindala, Venkataraman ^{[3
]}

Agarwal, Mohit ^{[1
]}

Fulop, Tibor ^{[4
,5
]}

机构：

[1] Univ Mississippi, Med Ctr, Dept Internal Med, Div Nephrol, Jackson, MS 39216 USA

[2] Univ Mississippi, Med Ctr, Div Endocrinol, Jackson, MS 39216 USA

[3] Univ Mississippi, Med Ctr, Div Hosp Med, Jackson, MS 39216 USA

[4] Univ Debrecen, Fac Med, Dept Med, Div Nephrol, Debrecen, Hungary

[5] Fresenius Med Care, FMC Extracorporeal Life Support Ctr, Esztergom, Hungary

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2018年 / 355卷 / 05期

关键词：

Alkaline phosphatase; End-stage renal disease; Hypercalcemia of malignancy; Parathyroid hormone; RANKL inhibitor; MULTIPLE-MYELOMA; BONE METASTASES; OSTEOPROTEGERIN; CANCER; ACID;

D O I：

10.1016/j.amjms.2017.09.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Denosumab is a monoclonal antibody directed against the receptor activator of nuclear factor kappa B ligand (RANKL). Denosumab has been shown to reduce the risk of skeletal-related events, including spinal cord compression, pathologic fracture and hypercalcemia of malignancy in patients with bone metastases. Hypocalcemia is a known side effect of denosumab, occurring in an estimated 8-14% of the patients. Here, we present an asymptomatic patient with stage-5 chronic kidney disease and severe hypocalcemia who had received denosumab 1 month earlier.

引用

页码：506 / 509

页数：4

共 50 条

[1] DENOSUMAB ASSOCIATED SEVERE HYPOCALCEMIA IN A PATIENT WITH CHRONIC KIDNEY DISEASE
Williams, M. H.
Williams, R. A.
Salim, S.
Sheehan, N.
JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 486 - 486
[2] Denosumab-Associated Severe Symptomatic Hypocalcemia in a Patient with Multiple Myeloma and AKI
Hadji, Nerihan
Shah, Hitesh H.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[3] Severe hypocalcemia following denosumab injection in patient with chronic kidney disease
Monge Rafael, Pilar
Arias, Manuel
Fernandez-Fresnedo, Gema
NEFROLOGIA, 2016, 36 (04): : 446 - 448
[4] Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients
Schoenmakers, Inez
Fraser, William D.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21):
[5] Case report: Recurrent severe hypocalcemia secondary to denosumab in a patient with chronic kidney disease
Correia, Margarida
Pereira, Paulo
Ferreira, Carla Campinho
Cerqueira, Marcos
Almeida, Diogo Esperanca
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (06)
[6] Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report
Kouroglou, Eleni
Tsiama, Vasiliki
Dionysopoulou, Sofia
Gavriiloglou, Georgios
Bora, Margarita
Belis, Konstantinos
Proikaki, Stella
Savvidis, Christos
Giannou, Panagiota
Petras, Dimitrios
JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2023, 23 (02) : 285 - 289
[7] Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients-Reply
Bird, Steven T.
Gelperin, Kate
Graham, David J.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21):
[8] Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease
Hsu, Chia-Tien
Deng, Ya-Lian
Chung, Mu-Chi
Tsai, Shang-Feng
Lin, Shih-Yi
Chen, Cheng-Hsu
HEALTHCARE, 2023, 11 (03)
[9] Denosumab-associated hypocalcemia: Does gender play a role?
Diker-Cohen, Talia
Amitai, Oren
Shochat, Tzippy
Shimon, Ilan
Tsvetov, Gloria
MATURITAS, 2020, 142 : 17 - 23
[10] Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review
Marlow, Christina F.
Sharma, Shailendra
Babar, Faizan
Lin, Jianqing
CASE REPORTS IN ONCOLOGICAL MEDICINE, 2018, 2018

← 1 2 3 4 5 →